Advertisements



PLx Pharma Inc. Reports Second Quarter 2018 Results

HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on c.....»»

Category: earningsSource: benzingaAug 10th, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»

Category: earningsSource: benzingaDec 13th, 2018

Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results

Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results.....»»

Category: smallbizSource: nytNov 28th, 2018

China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results

HAIKOU CITY, China, Nov. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE:CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully.....»»

Category: earningsSource: benzingaNov 15th, 2018

PLx Pharma Inc. Reports Third Quarter 2018 Results

PLx has identified the alternate supply of a key ingredient for Vazalore HOUSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commerciali.....»»

Category: earningsSource: benzingaNov 9th, 2018

Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results

- Continued advancement of endocrinology rare disease pipeline, paving way for application of TransCo.....»»

Category: earningsSource: benzingaAug 29th, 2018

Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update

Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update Enrolled more than 95% of .....»»

Category: earningsSource: benzingaAug 15th, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fisca.....»»

Category: earningsSource: benzingaAug 14th, 2018

PLx Pharma Inc. Reports Second Quarter 2018 Results

HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on c.....»»

Category: earningsSource: benzingaAug 10th, 2018

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance Acquires WellSpring Pharma Services for $18 Million in Cash to Expand Contract Manufacturing Business and Accelerate ANDA Pipeline .....»»

Category: earningsSource: benzingaAug 7th, 2018

Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements

CONSHOHOCKEN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharma.....»»

Category: earningsSource: benzingaAug 7th, 2018

Ascendis Pharma A/S Reports First Quarter 2018 Financial Results

- Continued.....»»

Category: earningsSource: benzingaMay 30th, 2018

Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update

Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update More than 350 patients enrolled in pivotal Phase 3 A.....»»

Category: earningsSource: benzingaMay 15th, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fisc.....»»

Category: earningsSource: benzingaMay 14th, 2018

Evoke Pharma Reports First Quarter 2018 Results and Highlights

NDA submission for Gimoti™ on track for second quarter of 2018 Announced.....»»

Category: earningsSource: benzingaMay 14th, 2018

PLx Pharma Inc. Reports First Quarter 2018 Results

HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceu.....»»

Category: earningsSource: benzingaMay 11th, 2018

MEI Pharma Reports Third Quarter Fiscal Year 2018 Results

MEI Pharma Reports Third Quarter Fiscal Y.....»»

Category: earningsSource: benzingaMay 9th, 2018

Recro Pharma Reports First Quarter 2018 Financial Results

Recro Pharma Reports First Quarter 2018 Financial Results.....»»

Category: earningsSource: benzingaMay 9th, 2018

Hollysys Automation Technologies Reports Unaudited Financial Results for the Second Quarter and the First Half Year Ended December 31, 2018

First Half Year of Fiscal Year 2019 Financial Highlights Non-GAAP net income attributable to Hollysys was $72.4 million, an increase of 24.3% co.....»»

Category: earningsSource: benzinga13 hr. 12 min. ago

FHLB Des Moines Reports 2018 Preliminary Unaudited Financial Results and Fourth Quarter 2018 Dividend

DES MOINES, Iowa, Feb. 15, 2019 (GLOBE NEWSW.....»»

Category: earningsSource: benzinga13 hr. 12 min. ago

ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2018

-$0.04/share for the 12.....»»

Category: earningsSource: benzinga17 hr. 27 min. ago